Top Markets
#1 Ontology Gas Ontology Gas +19.23%
#2 Status Status +13.13%
#3 Gas Gas +7.44%
#4 Fake World Assets Fake World Assets +5.29%
#5 Tornado Cash Tornado Cash +5.29%
#6 B3 (Base) B3 (Base) +5.22%
#7 aelf aelf +5.17%
#8 BCGame Coin BCGame Coin +4.98%
#9 Ontology Ontology +4.37%
#10 The Black Bull The Black Bull +4.32%
Coin of the day
Ontology Gas Ontology Gas
Setări
Limbă
ROMâNă
Monedă
USD
Temă
LAVA Therapeutics N.V. LAVA Therapeutics N.V.

LAVA Therapeutics N.V.

LVTX
Rang în acțiuni #25847
LAVA Therapeutics N.V. is an immuno-oncology firm, currently in the clinical... LAVA Therapeutics N.V. is an immuno-oncology firm, currently in the clinical development phase, dedicated to pioneering novel therapies for cancer. Utilizing its proprietary Gammabody platform, the company engineers innovative bispecific antibodies. These antibodies are specifically designed to engage and harness the potent and precise capabilities of gamma delta T cells, aiming to stimulate a robust anti-tumor immune response and ultimately enhance outcomes for individuals battling cancer. Key compounds in its clinical pipeline include LAVA-051, currently undergoing Phase 1/2a trials for various hematologic malignancies such as chronic lymphocytic leukemia, multiple myeloma, and acute myeloid leukemia. Another front-runner, LAVA-1207, is also in Phase 1/2a clinical studies, targeting metastatic castration-resistant prostate cancer. Furthermore, LAVA Therapeutics is advancing additional Gammabody candidates: LAVA-1223, an investigational treatment for specific solid tumors that targets the epidermal growth factor receptor (EGFR), and preclinical assets LAVA-1266 and LAVA-1278, intended for a range of blood cancers. The company has also forged a research collaboration and licensing partnership with Janssen Biotech, Inc. This alliance focuses on the potential discovery and development of multi-specific antibody therapies aimed at a particular target across diverse therapeutic applications. Established in 2016, LAVA Therapeutics N.V. operates from its headquarters in Utrecht, the Netherlands.
Preț acțiune
$1.74
Ultima sincronizare: 2025-11-28
Capitalizare de piață
$45.77M
Schimbare (1 zi)
0.00%
Schimbare (1 an)
12.26%
Țară
NL
Tranzacționează LAVA Therapeutics N.V. (LVTX)

Categorie

Healthcare
Istoric al prețului acțiunii pentru LAVA Therapeutics N.V. (LVTX)
Cel mai mare preț de închidere: $1.68 pe 2025-11-01

Cel mai mic preț de închidere: $13.74 pe 2021-03-01
Istoric al prețului acțiunii pentru LAVA Therapeutics N.V. din 2021 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) -5.21%
2025 33.22%
2024 -17.20%
2023 -67.44%
2022 -17.89%
2021 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $539.14 35.65%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 56.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $119.69 -17.56%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $761.87 8.65%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $130.43 397.46%
US